Type 2 diabetes as a disease of ectopic fat? - Wikidata - awgldk - TriplyDB

Type 2 diabetes as a disease of ectopic fat?

Type 2 diabetes as a disease of ectopic fat?

http://www.wikidata.org/entity/Q27022915

about

Mesenchymal Stem Cells and Metabolic Syndrome: Current Understanding and Potential Clinical Implications Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease.Impact of fat mass and distribution on lipid turnover in human adipose tissue Environmental/lifestyle factors in the pathogenesis and prevention of type 2 diabetes.Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study A Class of Diacylglycerol Acyltransferase 1 Inhibitors Identified by a Combination of Phenotypic High-throughput Screening, Genomics, and Genetics Anti-diabetic activities of catalpol in db/db mice.Reversibility of β-Cell-Specific Transcript Factors Expression by Long-Term Caloric Restriction in db/db Mouse.DiabCare survey of diabetes management and complications in the Gulf countries.Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies.Associations between weight change and biomarkers of cardiometabolic risk in South Asians: secondary analyses of the PODOSA trial.Noninvasive fat quantification of the liver and pancreas may provide potential biomarkers of impaired glucose tolerance and type 2 diabetes Deletion of angiotensin II type 2 receptor accelerates adipogenesis in murine mesenchymal stem cells via Wnt10b/beta-catenin signaling Effect of energy restriction and physical exercise intervention on phenotypic flexibility as examined by transcriptomics analyses of mRNA from adipose tissue and whole body magnetic resonance imaging.Effect of orlistat on glycaemic control in overweight and obese patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.Ectopic fat accumulation in the pancreas and its biomarkers: A systematic review and meta-analysis.Current and future strategies for the nutritional management of cardiometabolic complications of androgen deprivation therapy for prostate cancer.Mesenchymal stem cells in obesity: insights for translational applications.Pancreas Volume and Fat Deposition in Diabetes and Normal Physiology: Consideration of the Interplay Between Endocrine and Exocrine Pancreas Qizhi Jiangtang Jiaonang Improves Insulin Signaling and Reduces Inflammatory Cytokine Secretion and Reactive Oxygen Species Formation in Insulin Resistant HepG2 Cells.Intracellular Insulin and Impaired Autophagy in a Zebrafish model and a Cell Model of Type 2 diabetes.What are we to think when results from mouse research contradict those from human experiments and clinical practice?Rheumatoid arthritis: Debunking the obesity-mortality paradox in RA.Unfolding Novel Mechanisms of Polyphenol Flavonoids for Better Glycaemic Control: Targeting Pancreatic Islet Amyloid Polypeptide (IAPP).Sex Differences in the Excess Risk of Cardiovascular Diseases Associated with Type 2 Diabetes: Potential Explanations and Clinical Implications.Combination of Obestatin and Bone Marrow Mesenchymal Stem Cells Prevents Aggravation of Endocrine Pancreatic Damage in Type II Diabetic Rats.Prevalence of Pre-Diabetes across Ethnicities: A Review of Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT) for Classification of Dysglycaemia.Sex Differences in the Burden and Complications of Diabetes.Histopathological changes in rat pancreas and skeletal muscle associated with high fat diet induced insulin resistance.Meta- and cross-species analyses of insulin resistance based on gene expression datasets in human white adipose tissues.FGF21 gene therapy as treatment for obesity and insulin resistance Healthy obesity as an intermediate state of risk: a critical review

P2860

Q26745520-A4821460-29D3-4311-BA74-40DDD140F24E Q26750563-1C80A2FE-B73C-4891-BD0C-51D403C42995 Q28069643-14657063-0771-4810-9952-5D478EB7920D Q30251565-AC7D76AA-3462-44D1-9551-9C8D5CF19B60 Q33759091-8152D3E3-A84B-4387-B50C-3DF17A5B325E Q33916655-30E08FA6-7027-4FED-923E-2F72CAE93CF0 Q34503601-2D817CC6-FA84-496D-80FD-E98A882C6F36 Q34740328-A6784F34-0A29-49E6-A838-07FDC2352F8D Q36080184-7190F511-05D8-4B5D-AE94-FAD27BAE237E Q36627589-26D82C71-8FC2-4475-BFFE-FF9D2853C8A7 Q36655283-F11D8747-3881-47DD-8ACA-F0F97CEB0576 Q36687510-C2A79A36-5829-4A48-B6EB-795773AD776F Q36716045-27A04066-E01B-4A1A-BD75-56DF41D66CEB Q36966968-3E32C3DD-9F18-47FD-B7D9-49AB350E4DCD Q37003707-4C08FAB3-4124-4ED9-A68C-AA9A32B474C7 Q37136352-712AB606-58A4-4CF5-97E6-BD6093A16B03 Q37419016-0C9BFAB3-BE19-465D-822C-C3388CC97096 Q38582254-009E9DF9-F63D-4021-8C4B-1501BE6B670B Q38653928-372954FF-8D6A-47DA-AC8B-5F4E41732C48 Q38671819-B2083A30-FD22-49F4-AAAD-48B23B0D44F3 Q38729746-581E9B4D-7711-4DFF-AEA8-D912FEC33ED0 Q39052404-B34A097C-3DC5-4297-8B17-25BA0FAB380A Q40812702-4AE7112C-BE7E-464A-AC0D-66F66F8E18B6 Q41036138-F53765CC-B930-4DBD-948D-8AA7A3928C5E Q41085092-69FA604E-3270-4652-8279-29B9881C7554 Q41120020-C5C5024C-B3F0-44EB-8D17-1A1DA357E9A9 Q41195653-3DF3AD63-4B4E-47CB-AAB1-32AAD7265D1C Q42537111-AEA6C29F-4F4C-419B-8847-59B2D1DC83AE Q46726958-D8B54EC5-7AFA-43AB-B97C-1148EA93E5BA Q47168303-0221FD99-20E0-4AC5-BF01-C9A13D491513 Q52578791-6C38F66F-67AD-4AC6-8D53-E93378A13DD4 Q53509656-71A953B0-A033-4178-8E8D-6F83DCE8E37D Q53706040-C3EC171A-A742-484E-89C0-2C2C5B8552E2 Q57688659-E749EA3D-93B3-4E5A-8C4E-FF616B14632F Q59236424-36AFADF4-C796-4416-B821-26E6BECB6501

P2860

Type 2 diabetes as a disease of ectopic fat?

http://www.wikidata.org/entity/Q27022915

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Type 2 diabetes as a disease of ectopic fat?

@ast

Type 2 diabetes as a disease of ectopic fat?

@en

Type 2 diabetes as a disease of ectopic fat?

@nl

type

label

Type 2 diabetes as a disease of ectopic fat?

@ast

Type 2 diabetes as a disease of ectopic fat?

@en

Type 2 diabetes as a disease of ectopic fat?

@nl

prefLabel

Type 2 diabetes as a disease of ectopic fat?

@ast

Type 2 diabetes as a disease of ectopic fat?

@en

Type 2 diabetes as a disease of ectopic fat?

@nl

P1433

Q27022915-C32E50FB-B5F4-4613-BC24-E3547821E3FE

P1476

Q27022915-6CCE4BEE-BE97-4A4C-B662-C9128FC5FE8E

P2093

Q27022915-64E10E5C-B69C-4E16-8600-C1641D0B16F1

P275

Q27022915-60BA7B11-B410-475F-9518-BB35EC6A8236

P2860

Q27022915-012351BD-628A-4382-8C8C-EE7B8CE4D842

Q27022915-05AAE831-DF06-4507-AAE2-85465B374130

Q27022915-0B3FFEBE-6C10-4FB5-95B2-DAB81A84F29C

Q27022915-0BEE7E73-8F6A-420D-9674-463D20728CDE

Q27022915-0E18C3A7-8FA9-412A-94C8-9FA0358B1F9C

Q27022915-0FB8BA2F-06A8-4761-A043-4EEC722918F8

Q27022915-14670BF8-0806-4DE2-A532-8EB0E29C0C4C

Q27022915-210041EE-A321-4475-88F3-C88AF85B9419

Q27022915-38321772-046B-4B05-B37F-AC1BF46C6BD3

Q27022915-3841EF05-C0C2-42E6-A451-464C3756F45E

P2888

Q27022915-25E48868-5686-4236-94FE-4E49CD0B12E2

P304

Q27022915-680A53FD-F2BA-4D12-BBDD-1383FB3A008A

P31

Q27022915-1F90A263-4778-4822-A59B-3DAB48E4714F

Q27022915-E58F3DB3-18FA-41B4-A980-61D74A90BB2F

P3181

Q27022915-82859AC1-FEA5-4F06-9DE3-2C712C5E7F81

P356

Q27022915-CA36E93E-71B6-4898-9740-AD27B16EAEC3

P407

Q27022915-49B04747-2A90-4C70-A3C3-7A8AC8F3DC11

P478

Q27022915-2025038C-80FA-4653-8A37-269223B8EEE0

P50

Q27022915-A533A113-2351-4DCA-BBA2-169C665BD3A4

P5008

Q27022915-D09C7750-71D4-403F-A300-5D3A9084FB2F

P577

Q27022915-D2EAA5E9-6503-439F-A59E-91A947487CE0

P5875

Q27022915-2109F796-7B8E-453A-9246-B3DCB6D7F3E5

P6179

Q27022915-351A22E0-9693-4A00-B463-2FF09AC9ECB4

P698

Q27022915-2EF57C88-B305-4C78-A1D8-F0DCCF0F954E

P921

Q27022915-1739A210-E65D-4366-9A8B-C053FF3E3CCD

Q27022915-3B195001-6CC5-48A6-A483-F9851D18EF23

Q27022915-D774426D-AFBC-472F-8360-43BABD6FC340

Q27022915-E66904EC-C288-4683-A4B6-B567C9B93FAE

P932

Q27022915-82A894B9-BDB1-4C7B-BBAF-A0F67B1F0A50

P3181

P356

S12916-014-0123-4

P1433

P1476

Type 2 diabetes as a disease of ectopic fat?

@en

P2093

Jason MR Gill

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution

P2860

FTO: the first gene contributing to common forms of human obesity

A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013

Insulin resistance and body fat distribution in South Asian men compared to Caucasian men

Nutrient sensing and inflammation in metabolic diseases.

Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes.

Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol.

Do men develop type 2 diabetes at lower body mass indices than women?

Identification and characterization of metabolically benign obesity in humans.

Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause.

P2888

s12916-014-0123-4

P304

123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1210298

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/S12916-014-0123-4

http://www.w3.org/2001/XMLSchema#string

P407

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2014-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265095961

http://www.w3.org/2001/XMLSchema#string

P6179

1004201114

http://www.w3.org/2001/XMLSchema#string

P698

25159817

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

maturity-onset diabetes of the young

physiological phenomena

P932

4143560

http://www.w3.org/2001/XMLSchema#string